E
AN2 Therapeutics, Inc. ANTX
$1.15 $0.043.60% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 55.23% 35.92% 55.49% 23.70% 8.66%
Total Depreciation and Amortization -- -- -- -- --
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 23.03% 23.96% 30.99% -23.41% -8.12%
Change in Net Operating Assets -113.23% 30.44% 194.53% -112.76% -190.05%
Cash from Operations 47.17% 39.61% 69.11% -1.75% -12.16%
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -64.56% -65.03% -1,738.10% 129.97% 108.96%
Cash from Investing -64.56% -65.03% -1,738.10% 129.97% 108.96%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -- -81.38% -- -99.97% -100.00%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -- -81.38% 100.00% -99.97% -100.00%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -185.02% -115.10% 28.38% 182.17% -85.28%